Clinical Trials Logo

Clinical Trial Summary

This study will analyze whether dairy in combination with creatine supplementation will positively impact loading exercise-induced bone cell activity in healthy young females more than dairy and exercise or exercise alone.

Clinical Trial Description

Introduction: Two million individuals at a cost of around 2.3 billion dollars a year in Canada suffer from osteoporosis. Research that emphasizes the treatment of this disease is important, but so is research that focuses on prevention; reducing bone loss and/or increasing bone mass when young. Countermeasures to improve bone health, such as nutrition and exercise, should be explored and implemented, particularly during young adulthood when peak bone mass is achieved so that the burden of osteoporosis later in life can be mitigated. The proposed research combines both nutrition and exercise along with the assessment of bone turnover markers in healthy young females, and aims to determine whether dairy in combination with creatine supplementation positively impacts acute bone turnover following a bout of resistance and plyometric exercise.

Design: Randomized triple crossover trial.

Participants: 10 healthy university aged females.

Methods: Participants will be asked to complete 3 different acute exercise and nutritional supplement trials. Each trial will be assigned in random order. The three trials are: 1) exercise+carbohydrate (CHO), 2) exercise+milk (Milk), and 3) exercise+milk+creatine (Cre). The whole study will take a maximum of 12 weeks to complete as each supplement trial will be separated by 2-4 weeks. Each treatment is outlined below.

Anticipated Results: The investigators anticipate that creatine in conjunction with dairy and exercise will have a greater positive impact on acute bone cell activity in healthy young females more than dairy+exercise and more than exercise alone. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03615989
Study type Interventional
Source Brock University
Contact Andrea Josse, PhD
Phone 1 905-688-5550
Status Recruiting
Phase N/A
Start date October 1, 2018
Completion date December 2019

See also
  Status Clinical Trial Phase
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1
Terminated NCT00001844 - Study of New Magnetic Resonance Methods
Completed NCT03160261 - Effect of Exenatide on Cortisol Secretion Phase 4
Completed NCT03662100 - A Study of Two Formulations of LY3074828 in Healthy Participants Phase 1
Recruiting NCT02875301 - Investigating Gains in Neurocognition in an Intervention Trial of Exercise Phase 3
Completed NCT03656952 - A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers Phase 1
Completed NCT03670082 - Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State Phase 1
Completed NCT03203824 - The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals N/A
Completed NCT03056846 - Probiotics on Stress-associated Gastrointestinal Function in University Students N/A
Completed NCT03677375 - Hemodilution Validation of INVSENSOR00026 N/A
Recruiting NCT03114839 - Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN) N/A
Completed NCT03259464 - This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated Phase 1
Completed NCT03224702 - First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers Phase 1
Completed NCT03309566 - Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir Phase 4
Completed NCT00527579 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Phase 1
Completed NCT00526916 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Phase 1
Not yet recruiting NCT03807973 - Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. Phase 1
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03373162 - Functional Effects of Botox on the Brain Using MRS and fMRI Phase 4